Literature DB >> 29574609

Outcome of immature oocytes collection of 119 cancer patients during ovarian tissue harvesting for fertility preservation.

Alon Kedem1, Gil M Yerushalmi1, Masha Brengauz1, Hila Raanani1, Raoul Orvieto1, Ariel Hourvitz1, Dror Meirow2.   

Abstract

PURPOSE: Few clinical options for fertility preservation are available to females with cancer, and data about clinical outcomes is limited. Potential supplementary approaches to fertility preservation include retrieval of immature oocytes followed by in vitro maturation (IVM) and storage. The aim of this study was to evaluate post-thawing outcomes of immature oocytes collected both by transvaginal aspiration and from excised ovarian tissue.
METHODS: We conducted a retrospective cohort study of patients treated in a single tertiary center. We reviewed the records of 119 cancer patients who underwent ovarian tissue cryopreservation and immature oocyte harvesting for fertility preservation. All embryos and oocytes that were frozen and thawed were included in the study. Post-thawing outcomes were evaluated.
RESULTS: Thirty-five stored embryos from eight patients were thawed. Twenty-nine embryos survived (82% survival rate) and were transferred. Six oocytes were thawed, two oocytes survived, and no oocytes were fertilized. Only one PCOS patient became pregnant, resulting in the normal delivery of a healthy baby.
CONCLUSIONS: Although a relatively high number of mature oocytes and embryos can be stored with the combined procedure, the limited rate of pregnancies represents a poor reproductive outcome. Therefore, this approach should be reserved for special groups with limited options.

Entities:  

Keywords:  Fertility preservation; In vitro oocyte maturation; Oocyte retrieval

Mesh:

Year:  2018        PMID: 29574609      PMCID: PMC5984891          DOI: 10.1007/s10815-018-1153-1

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  30 in total

1.  Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations.

Authors:  D Meirow; M Epstein; H Lewis; D Nugent; R G Gosden
Journal:  Hum Reprod       Date:  2001-04       Impact factor: 6.918

Review 2.  Options on fertility preservation in female cancer patients.

Authors:  Kenny A Rodriguez-Wallberg; Kutluk Oktay
Journal:  Cancer Treat Rev       Date:  2011-11-09       Impact factor: 12.111

3.  Combination of ovarian tissue harvesting and immature oocyte collection for fertility preservation increases preservation yield.

Authors:  A Hourvitz; G M Yerushalmi; E Maman; H Raanani; S Elizur; M Brengauz; R Orvieto; J Dor; D Meirow
Journal:  Reprod Biomed Online       Date:  2015-07-13       Impact factor: 3.828

4.  Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients.

Authors:  Dror Meirow; Izhar Hardan; Jehoshua Dor; Eduard Fridman; Shai Elizur; Hila Ra'anani; Elena Slyusarevsky; Ninette Amariglio; Eyal Schiff; Gideon Rechavi; Arnon Nagler; Dina Ben Yehuda
Journal:  Hum Reprod       Date:  2008-03-15       Impact factor: 6.918

5.  What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation?

Authors:  C Sonigo; C Simon; M Boubaya; A Benoit; C Sifer; N Sermondade; M Grynberg
Journal:  Hum Reprod       Date:  2016-05-10       Impact factor: 6.918

6.  Ovarian tissue cryopreservation and transplantation: a realistic, effective technology for fertility preservation.

Authors:  Dror Meirow; Hila Ra'anani; Hannah Biderman
Journal:  Methods Mol Biol       Date:  2014

7.  Reproduction rates after cancer treatment: experience from the Norwegian radium hospital.

Authors:  Milada Cvancarova; Sven Ove Samuelsen; Henriette Magelssen; Sophie Dorothea Fosså
Journal:  J Clin Oncol       Date:  2008-12-15       Impact factor: 44.544

8.  At what age can human oocytes be obtained?

Authors:  Ariel Revel; Shoshana Revel-Vilk; Einat Aizenman; Anat Porat-Katz; Anat Safran; Assaf Ben-Meir; Michael Weintraub; Michael Shapira; Hanna Achache; Neri Laufer
Journal:  Fertil Steril       Date:  2008-10-26       Impact factor: 7.329

9.  Effect of different gonadotrophin priming on IVM of oocytes from women with normal ovaries: a prospective randomized study.

Authors:  R Fadini; M B Dal Canto; M Mignini Renzini; F Brambillasca; R Comi; D Fumagalli; M Lain; M Merola; R Milani; E De Ponti
Journal:  Reprod Biomed Online       Date:  2009-09       Impact factor: 3.828

10.  Ovarian tissue cryopreservation and transplantation in cancer patients.

Authors:  Jacques Donnez; Pascale Jadoul; Jean Squifflet; Anne Van Langendonckt; Olivier Donnez; Anne-Sophie Van Eyck; Cristina Marinescu; Marie-Madeleine Dolmans
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2009-10-21       Impact factor: 5.237

View more
  9 in total

1.  Cryopreservation of euploid blastocysts obtained after fertilization of in vitro matured ovarian tissue oocytes: a case report.

Authors:  Anastasia Kirillova; Evgeniya Kovalskaya; Olga Brovkina; Aleksey Ekimov; Ekaterina Bunyaeva; Marat Gordiev; Nona Mishieva; Tatiana Nazarenko; Aydar Abubakirov; Gennady Sukikh
Journal:  J Assist Reprod Genet       Date:  2020-03-24       Impact factor: 3.412

2.  Fertility Preservation for Child and Adolescent Cancer Patients in Asian Countries.

Authors:  Seido Takae; Jung Ryeol Lee; Nalini Mahajan; Budi Wiweko; Nares Sukcharoen; Virgilio Novero; Antoinette Catherine Anazodo; Debra Gook; Chii-Ruey Tzeng; Alexander Kenenth Doo; Wen Li; Chau Thi Minh Le; Wen Di; Ri-Cheng Chian; Seok Hyun Kim; Nao Suzuki
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-15       Impact factor: 5.555

3.  Installing oncofertility programs for common cancers in optimum resource settings (Repro-Can-OPEN Study Part II): a committee opinion.

Authors: 
Journal:  J Assist Reprod Genet       Date:  2021-01-16       Impact factor: 3.412

4.  Installing oncofertility programs for breast cancer in limited versus optimum resource settings: Empirical data from 39 surveyed centers in Repro-Can-OPEN Study Part I & II.

Authors:  Mahmoud Salama; M Lambertini; M S Christianson; Y Jayasinghe; A Anazodo; M De Vos; F Amant; C Stern; L Appiah; T L Woodard; R A Anderson; L M Westphal; R E Leach; K A Rodriguez-Wallberg; P Patrizio; Teresa K Woodruff
Journal:  J Assist Reprod Genet       Date:  2022-01-15       Impact factor: 3.357

5.  Preservation of female fertility in humans and animal species.

Authors:  Helen Mary Picton
Journal:  Anim Reprod       Date:  2018-08-17       Impact factor: 1.807

6.  Improved maturation competence of ovarian tissue oocytes using a biphasic in vitro maturation system for patients with gynecological malignancy: a study on sibling oocytes.

Authors:  Anastasia Kirillova; Ekaterina Bunyaeva; Heidi Van Ranst; Grigory Khabas; Maria Farmakovskaya; Nail Kamaletdinov; Tatiana Nazarenko; Aydar Abubakirov; Gennady Sukhikh; Johan E J Smitz
Journal:  J Assist Reprod Genet       Date:  2021-02-22       Impact factor: 3.357

Review 7.  Cryopreservation of Ovarian Tissue: Opportunities Beyond Fertility Preservation and a Positive View Into the Future.

Authors:  Stine G Kristensen; Claus Y Andersen
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-28       Impact factor: 5.555

Review 8.  Human Ovarian Cortex biobanking: A Fascinating Resource for Fertility Preservation in Cancer.

Authors:  Erica Silvestris; Giuseppe De Palma; Stefano Canosa; Simone Palini; Miriam Dellino; Alberto Revelli; Angelo Virgilio Paradiso
Journal:  Int J Mol Sci       Date:  2020-05-04       Impact factor: 5.923

9.  Oncofertility case report: live birth 10 years after oocyte in vitro maturation and zygote cryopreservation.

Authors:  P Rodrigues; M Marques; S Pimentel; M Rato; P Carvalho; S C Correia; N Mendes; H Amaral; J P Fernandes; M J Carvalho; C E Plancha
Journal:  J Assist Reprod Genet       Date:  2020-10-28       Impact factor: 3.412

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.